Multifiling Mitra Indonesia Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Multifiling Mitra Indonesia Tbk. trades at Rp1,300 (market cap 984.86B), while Tempo Scan Pacific Tbk. trades at Rp2,730 (market cap 12.36T, 1.41M 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 12.6× Multifiling Mitra Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| MFMI | TSPC | |
|---|---|---|
Market Cap | 984.86B | 12.36T |
Volume | — | 1.41M |
Lot | — | 14.08K |
Turnover | — | 3.83B |
Average Price | — | 2,722.04 |
Value | — | 3.83B |
Indicative Equilibrium Price | — | 2,730 |
Indicative Equilibrium Volume | — | 2.51K |
Trailing returns across standard periods
Latest headlines on both assets
PT Multifiling Mitra Indonesia Tbk (the Company) was established based on the Notarial Deed No. 157 of Misahardi Wilamarta, SH., dated July 9, 1992. MMI is a joint venture company between PT.Multipolar Corp. Tbk. and PT. Lippo Karawaci Tbk, currently serving its customers in 4-big city, Jakarta, Surabaya, Medan dan Bandung.
Read more on MFMI →PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →